Inventor · disambiguated record
Anatoly Dritschilo
Also filed as: DRITSCHILO ANATOLY
24 granted patents·17 pending applications·610 citations·filing 1993–2025
96Inventor score
Files withSHUTTLE PHARMACEUTICALS INC13UNIV GEORGETOWN12GEORGETOWN UNIVERSITY SCHOOL O4DRITSCHILO ANATOLY3KOZIKOWSKI ALAN P3
Top patents by PatentIndex Score
41 records- 0196US5665710AMethod of making liposomal oligodeoxynucleotide compositionsUNIV GEORGETOWN·Filed 1993·Granted Sep 9, 1997·255 cites·3 claims
- 0291US6333314B1Liposomes containing oligonucleotidesGEORGETOWN UNIVERSITY SCHOOL O·Filed 2000·Granted Dec 25, 2001·35 cites·7 claims
- 0390US6126965ALiposomes containing oligonucleotidesGEORGETOWN UNIVERSITY SCHOOL O·Filed 1997·Granted Oct 3, 2000·84 cites·13 claims
- 0488US8222451B2Histone deacetylase inhibitors and methods of use thereofKOZIKOWSKI ALAN P·Filed 2010·Granted Jul 17, 2012·9 cites·5 claims
- 0585US8748463B2Histone deacetylase inhibitors and methods of use thereofKOZIKOWSKI ALAN P·Filed 2012·Granted Jun 10, 2014·6 cites·9 claims
- 0685US7842835B2Histone deacetylase inhibitors and methods of use thereofUNIV GEORGETOWN·Filed 2003·Granted Nov 30, 2010·17 cites·11 claims
- 0784US6559129B1Cationic liposomal delivery system and therapeutic use thereofUNIV GEORGETOWN·Filed 2000·Granted May 6, 2003·31 cites·10 claims
- 0883US12357650B2Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiationSHUTTLE PHARMACEUTICALS INC·Filed 2023·Granted Jul 15, 2025·0 cites·14 claims
- 0983US5756122ALiposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cellsUNIV GEORGETOWN·Filed 1995·Granted May 26, 1998·62 cites·18 claims
- 1081US9809539B2Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS LLC·Filed 2015·Granted Nov 7, 2017·4 cites·6 claims
- 1179US8653278B2Isoform selective HDAC inhibitorsKOZIKOWSKI ALAN P·Filed 2007·Granted Feb 18, 2014·5 cites·10 claims
- 1279US8293513B2Histone deacetylase inhibitorsBROWN MILTON L·Filed 2008·Granted Oct 23, 2012·4 cites·21 claims
- 1378US2025302857A1Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With RadiationSHUTTLE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1477US2023302034A1Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With RadiationSHUTTLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1575US12077515B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2022·Granted Sep 3, 2024·0 cites·20 claims
- 1674US2022055988A1Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1773US7262173B2Chemosensitizing with liposomes containing oligonucleotidesNEOPHARM INC·Filed 2002·Granted Aug 28, 2007·7 cites·12 claims
- 1869US2020317611A1Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1969US2024174630A1Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2068US10730834B2Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2017·Granted Aug 4, 2020·0 cites·10 claims
- 2168US6665555B2Radiosurgery methods that utilize stereotactic methods to precisely deliver high dosages of radiation especially to the spineGEORGETOWN UNIVERSITY SCHOOL O·Filed 2001·Granted Dec 16, 2003·65 cites·15 claims
- 2267US11654157B2Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiationSHUTTLE PHARMACEUTICALS INC·Filed 2018·Granted May 23, 2023·0 cites·10 claims
- 2365US11407723B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2019·Granted Aug 9, 2022·0 cites·5 claims
- 2464US11584733B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2021·Granted Feb 21, 2023·0 cites·20 claims
- 2563US10745352B2Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2016·Granted Aug 18, 2020·0 cites·4 claims
- 2662US5560923AMethod of encapsulating anthracycline in liposomesUNIV GEORGETOWN·Filed 1994·Granted Oct 1, 1996·26 cites·27 claims
- 2762US2007104718A1Gene BRCC-1 and diagnostic and therapeutic uses thereofGOKHALE PRAFULLA·Filed 2006·Application pending·0 cites
- 2860US2006141020A1Liposomes containing oligonucleotidesUNIV GEORGETOWN·Filed 2004·Application pending·0 cites
- 2957US2003228317A1Gene BRCC-1 and diagnostic and therapeutic uses thereofFiled 2003·Application pending·0 cites
- 3054US2010143242A1Delivery system for therapy comprising hollow seeds, and the method of use thereofDRITSCHILO ANATOLY·Filed 2009·Application pending·0 cites
- 3153US2005222013A1Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapyUNIV GEORGETOWN·Filed 2004·Application pending·0 cites
- 3251US2005287158A1The p65 subunit of nf-kb for the radiosensitization of cellsUNIV GEORGETOWN·Filed 2003·Application pending·0 cites
- 3350US2022065863A1Predictive biomarkers for adverse effects of radiation therapyUNIV GEORGETOWN·Filed 2021·Application pending·0 cites
- 3448US11034667B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2018·Granted Jun 15, 2021·0 cites·6 claims
- 3548US2006173443A1Delivery system for therapy comprising hollow seed, preferably polymericDRITSCHILO ANATOLY·Filed 2006·Application pending·0 cites
- 3648US2006173442A1Delivery system for therapy comprising hollow seed, the method of use thereofDRITSCHILO ANATOLY·Filed 2006·Application pending·0 cites
- 3747US7442520B2Gene BRCC-3 and diagnostic and therapeutic uses thereofUNIV GEORGETOWN·Filed 2003·Granted Oct 28, 2008·0 cites·8 claims
- 3847US7253272B2Gene BRCC-2 and diagnostic and therapeutic uses thereofUNIV GEORGETOWN·Filed 2003·Granted Aug 7, 2007·0 cites·4 claims
- 3946US2003229040A1Cationic liposomal delivery system and therapeutic use thereofUNIV GEORGETOWN·Filed 2003·Application pending·0 cites
- 4044US2004067904A1Gene therapy for prostate cancer: sensibilization of cells to dna damaging drugs and radiationFiled 2001·Application pending·0 cites
- 4129US2002160038A1Liposomes containing oligonucleotidesGEORGETOWN UNIVERSITY SCHOOL O·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anatoly Dritschilo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →